Cite
Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study
MLA
Leo J. Schouten, et al. Hypertension, Antihypertensives and Mutations in the Von Hippel-Lindau Gene in Renal Cell Carcinoma: Results from the Netherlands Cohort Study. Jan. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a1668f843fa8c963e096b8f21e8ce6e&authtype=sso&custid=ns315887.
APA
Leo J. Schouten, B.A.C. van Dijk, J.A. Schalken, Egbert Oosterwijk, Lambertus A. Kiemeney, R.A. Goldbohm, C.A. Hulsbergen van de Kaa, & P.A. van den Brandt. (2005). Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study.
Chicago
Leo J. Schouten, B.A.C. van Dijk, J.A. Schalken, Egbert Oosterwijk, Lambertus A. Kiemeney, R.A. Goldbohm, C.A. Hulsbergen van de Kaa, and P.A. van den Brandt. 2005. “Hypertension, Antihypertensives and Mutations in the Von Hippel-Lindau Gene in Renal Cell Carcinoma: Results from the Netherlands Cohort Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a1668f843fa8c963e096b8f21e8ce6e&authtype=sso&custid=ns315887.